| Financial Year |
March 31 2023 |
| Monetary Funds |
48,078,754.84 |
| Held-for-trading Financial Assets |
4,470,000.00 |
| Notes Receivable |
3,168,265.81 |
| Accounts Receivable |
226,326,898.24 |
| Advances to Suppliers |
72,863,336.81 |
| Other Receivables |
139,019,437.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
111,804,279.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,658,931.46 |
| Total Current Assets |
704,550,021.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
6,323,114.10 |
| Fixed Assetes |
215,170,730.02 |
| Under-construction Projects |
32,324,701.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
47,317,588.70 |
| R&D expenses |
-- |
| Goodwill |
15,393.45 |
| Long-Term Deferred and Prepaid Expenses |
931,651.68 |
| Deferred Income Tax Assets |
63,010,429.33 |
| Other Non-Current Assets |
2,856,000.01 |
| Sub-Total of Non-Current Assets |
397,889,392.86 |
| Total Assets |
1,102,439,414.68 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
124,716,287.01 |
| Accounts Payable |
100,832,233.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,934,279.66 |
| Taxes Payable |
4,953,333.86 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
47,720,790.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,435,241.32 |
| Other Current Liabilities |
2,112,565.91 |
| Sub-Total of Current Liabilities |
320,898,018.20 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
586,988.71 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
14,699,120.14 |
| Total Liabilities |
335,597,138.34 |
| Paid-In Capital(Or Share Stock) |
489,205,300.00 |
| Capital Surplus |
50,946,001.81 |
| Surplus Reserve |
92,679,785.10 |
| LESS:Treasury Stock |
40,087,316.10 |
| Undistributed Profits |
179,448,376.24 |
| Minority Stockholder's Interest |
-1,095,569.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
767,937,845.65 |
| Owner's Equity（Stockholder's Equity） |
766,842,276.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,102,439,414.68 |
